APO Research
Talk to an analyst

APO RESEARCH · REPORT

Endocrinology Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Endocrinology Drugs Industry Growth and Trends Forecast to 2032

22 December 202599 pages

Choose your research edition.

Industry ResearchEndocrinology Drugs Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Endocrinology Drugs Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Endocrinology Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Endocrinology Drugs Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Endocrinology Drugs Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Endocrinology Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Endocrinology Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Endocrinology Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Endocrinology Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Endocrinology Drugs include Sanofi, Novo Nordisk, Merck, Eli Lilly, AbbVie and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Endocrinology Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Endocrinology Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Endocrinology Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Endocrinology Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Endocrinology Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Endocrinology Drugs Market by Company

Sanofi

Novo Nordisk

Merck

Eli Lilly

AbbVie

AstraZeneca

Endocrinology Drugs Segment by Type

Diabetes Drugs

Human Growth Hormone Drugs

Thyroid Hormone Disorder Drugs

Testosterone Replacement Drugs

Endocrinology Drugs Segment by Application

Ambulatory Care Centres

Commercial Laboratories

Hospitals

Other Setting

Endocrinology Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endocrinology Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Endocrinology Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endocrinology Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Endocrinology Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Endocrinology Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Diabetes Drugs Table 2. Major Company of Human Growth Hormone Drugs Table 3. Major Company of Thyroid Hormone Disorder Drugs Table 4. Major Company of Testosterone Replacement Drugs Table 5. Global Endocrinology Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Endocrinology Drugs Sales by Type (2021-2026) & (k units) Table 7. Global Endocrinology Drugs Sales Market Share in Volume by Type (2021-2026) Table 8. Global Endocrinology Drugs Sales by Type (2021-2026) & (US$ Million) Table 9. Global Endocrinology Drugs Sales Market Share in Value by Type (2021-2026) Table 10. Global Endocrinology Drugs Price by Type (2021-2026) & (US$/unit) Table 11. Global Endocrinology Drugs Sales by Type (2027-2032) & (k units) Table 12. Global Endocrinology Drugs Sales Market Share in Volume by Type (2027-2032) Table 13. Global Endocrinology Drugs Sales by Type (2027-2032) & (US$ Million) Table 14. Global Endocrinology Drugs Sales Market Share in Value by Type (2027-2032) Table 15. Global Endocrinology Drugs Price by Type (2027-2032) & (US$/unit) Table 16. North America Endocrinology Drugs Sales by Type (2021-2026) & (k units) Table 17. North America Endocrinology Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Endocrinology Drugs Sales by Type (2021-2026) & (k units) Table 19. Europe Endocrinology Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Endocrinology Drugs Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Endocrinology Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Endocrinology Drugs Sales by Type (2021-2026) & (k units) Table 23. Latin America Endocrinology Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Endocrinology Drugs Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Endocrinology Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Endocrinology Drugs Industry Trends Table 27. Endocrinology Drugs Industry Drivers Table 28. Endocrinology Drugs Industry Opportunities and Challenges Table 29. Endocrinology Drugs Industry Restraints Table 30. Global Endocrinology Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Endocrinology Drugs Revenue Market Share by Company (2021-2026) Table 32. Global Endocrinology Drugs Sales by Company (2021-2026) & (k units) Table 33. Global Endocrinology Drugs Sales Share by Company (2021-2026) Table 34. Global Endocrinology Drugs Market Price by Company (2021-2026) & (US$/unit) Table 35. Global Endocrinology Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Endocrinology Drugs Major Company Production Sites and Headquarters Table 37. Global Endocrinology Drugs Company, Product Type & Application Table 38. Global Endocrinology Drugs Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Endocrinology Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Endocrinology Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Endocrinology Drugs Sales by Region (2021-2026) & (k units) Table 43. Global Endocrinology Drugs Sales Market Share in Volume by Region (2021-2026) Table 44. Global Endocrinology Drugs Sales by Region (2021-2026) & (US$ Million) Table 45. Global Endocrinology Drugs Sales Market Share in Value by Region (2021-2026) Table 46. Global Endocrinology Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 47. Global Endocrinology Drugs Sales by Region (2027-2032) & (k units) Table 48. Global Endocrinology Drugs Sales Market Share in Volume by Region (2027-2032) Table 49. Global Endocrinology Drugs Sales by Region (2027-2032) & (US$ Million) Table 50. Global Endocrinology Drugs Sales Market Share in Value by Region (2027-2032) Table 51. Global Endocrinology Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 52. Global Endocrinology Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Endocrinology Drugs Sales by Application (2021-2026) & (k units) Table 54. Global Endocrinology Drugs Sales Market Share in Volume by Application (2021-2026) Table 55. Global Endocrinology Drugs Sales by Application (2021-2026) & (US$ Million) Table 56. Global Endocrinology Drugs Sales Market Share in Value by Application (2021-2026) Table 57. Global Endocrinology Drugs Price by Application (2021-2026) & (US$/unit) Table 58. Global Endocrinology Drugs Sales by Application (2027-2032) & (k units) Table 59. Global Endocrinology Drugs Sales Market Share in Volume by Application (2027-2032) Table 60. Global Endocrinology Drugs Sales by Application (2027-2032) & (US$ Million) Table 61. Global Endocrinology Drugs Sales Market Share in Value by Application (2027-2032) Table 62. Global Endocrinology Drugs Price by Application (2027-2032) & (US$/unit) Table 63. North America Endocrinology Drugs Sales by Application (2021-2026) & (k units) Table 64. North America Endocrinology Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Endocrinology Drugs Sales by Application (2021-2026) & (k units) Table 66. Europe Endocrinology Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Endocrinology Drugs Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Endocrinology Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Endocrinology Drugs Sales by Application (2021-2026) & (k units) Table 70. Latin America Endocrinology Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Endocrinology Drugs Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Endocrinology Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Sanofi Company Information Table 74. Sanofi Business Overview Table 75. Sanofi Endocrinology Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Sanofi Endocrinology Drugs Product Portfolio Table 77. Sanofi Recent Development Table 78. Novo Nordisk Company Information Table 79. Novo Nordisk Business Overview Table 80. Novo Nordisk Endocrinology Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Novo Nordisk Endocrinology Drugs Product Portfolio Table 82. Novo Nordisk Recent Development Table 83. Merck Company Information Table 84. Merck Business Overview Table 85. Merck Endocrinology Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Merck Endocrinology Drugs Product Portfolio Table 87. Merck Recent Development Table 88. Eli Lilly Company Information Table 89. Eli Lilly Business Overview Table 90. Eli Lilly Endocrinology Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Eli Lilly Endocrinology Drugs Product Portfolio Table 92. Eli Lilly Recent Development Table 93. AbbVie Company Information Table 94. AbbVie Business Overview Table 95. AbbVie Endocrinology Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. AbbVie Endocrinology Drugs Product Portfolio Table 97. AbbVie Recent Development Table 98. AstraZeneca Company Information Table 99. AstraZeneca Business Overview Table 100. AstraZeneca Endocrinology Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. AstraZeneca Endocrinology Drugs Product Portfolio Table 102. AstraZeneca Recent Development Table 103. North America Endocrinology Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 104. North America Endocrinology Drugs Sales by Country (2021-2026) & (k units) Table 105. North America Endocrinology Drugs Sales Market Share by Country (2021-2026) Table 106. North America Endocrinology Drugs Sales Forecast by Country (2027-2032) & (k units) Table 107. North America Endocrinology Drugs Sales Market Share Forecast by Country (2027-2032) Table 108. North America Endocrinology Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. North America Endocrinology Drugs Market Size by Country (2021-2026) & (US$ Million) Table 110. North America Endocrinology Drugs Market Share by Country (2021-2026) Table 111. North America Endocrinology Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. North America Endocrinology Drugs Market Share Forecast by Country (2027-2032) Table 113. Europe Endocrinology Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 114. Europe Endocrinology Drugs Sales by Country (2021-2026) & (k units) Table 115. Europe Endocrinology Drugs Sales Market Share by Country (2021-2026) Table 116. Europe Endocrinology Drugs Sales Forecast by Country (2027-2032) & (k units) Table 117. Europe Endocrinology Drugs Sales Market Share Forecast by Country (2027-2032) Table 118. Europe Endocrinology Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Europe Endocrinology Drugs Market Size by Country (2021-2026) & (US$ Million) Table 120. Europe Endocrinology Drugs Market Share by Country (2021-2026) Table 121. Europe Endocrinology Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Europe Endocrinology Drugs Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Endocrinology Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Endocrinology Drugs Sales by Country (2021-2026) & (k units) Table 125. Asia-Pacific Endocrinology Drugs Sales Market Share by Country (2021-2026) Table 126. Asia-Pacific Endocrinology Drugs Sales Forecast by Country (2027-2032) & (k units) Table 127. Asia-Pacific Endocrinology Drugs Sales Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Endocrinology Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Endocrinology Drugs Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific Endocrinology Drugs Market Share by Country (2021-2026) Table 131. Asia-Pacific Endocrinology Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific Endocrinology Drugs Market Share Forecast by Country (2027-2032) Table 133. Latin America Endocrinology Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 134. Latin America Endocrinology Drugs Sales by Country (2021-2026) & (k units) Table 135. Latin America Endocrinology Drugs Sales Market Share by Country (2021-2026) Table 136. Latin America Endocrinology Drugs Sales Forecast by Country (2027-2032) & (k units) Table 137. Latin America Endocrinology Drugs Sales Market Share Forecast by Country (2027-2032) Table 138. Latin America Endocrinology Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Endocrinology Drugs Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Endocrinology Drugs Market Share by Country (2021-2026) Table 141. Latin America Endocrinology Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Endocrinology Drugs Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa Endocrinology Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa Endocrinology Drugs Sales by Country (2021-2026) & (k units) Table 145. Middle East and Africa Endocrinology Drugs Sales Market Share by Country (2021-2026) Table 146. Middle East and Africa Endocrinology Drugs Sales Forecast by Country (2027-2032) & (k units) Table 147. Middle East and Africa Endocrinology Drugs Sales Market Share Forecast by Country (2027-2032) Table 148. Middle East and Africa Endocrinology Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East and Africa Endocrinology Drugs Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East and Africa Endocrinology Drugs Market Share by Country (2021-2026) Table 151. Middle East and Africa Endocrinology Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East and Africa Endocrinology Drugs Market Share Forecast by Country (2027-2032) Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Endocrinology Drugs Distributors List Table 156. Endocrinology Drugs Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Endocrinology Drugs Image Figure 2. Global Endocrinology Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Endocrinology Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Endocrinology Drugs Sales (2021-2032) & (k units) Figure 5. Diabetes Drugs Image Figure 6. Global Diabetes Drugs Sales YoY Growth (2021-2032) & (k units) Figure 7. Human Growth Hormone Drugs Image Figure 8. Global Human Growth Hormone Drugs Sales YoY Growth (2021-2032) & (k units) Figure 9. Thyroid Hormone Disorder Drugs Image Figure 10. Global Thyroid Hormone Disorder Drugs Sales YoY Growth (2021-2032) & (k units) Figure 11. Testosterone Replacement Drugs Image Figure 12. Global Testosterone Replacement Drugs Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Endocrinology Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Endocrinology Drugs Market Share by Type 2025 VS 2032 Figure 15. North America Endocrinology Drugs Sales Market Share in Volume by Type in 2025 Figure 16. North America Endocrinology Drugs Sales Market Share in Value by Type in 2025 Figure 17. Europe Endocrinology Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Europe Endocrinology Drugs Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Endocrinology Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Endocrinology Drugs Sales Market Share in Value by Type in 2025 Figure 21. Latin America Endocrinology Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Endocrinology Drugs Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Endocrinology Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Endocrinology Drugs Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Endocrinology Drugs Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Ambulatory Care Centres Image Figure 28. Global Ambulatory Care Centres Sales YoY Growth (2021-2032) & (k units) Figure 29. Commercial Laboratories Image Figure 30. Global Commercial Laboratories Sales YoY Growth (2021-2032) & (k units) Figure 31. Hospitals Image Figure 32. Global Hospitals Sales YoY Growth (2021-2032) & (k units) Figure 33. Other Setting Image Figure 34. Global Other Setting Sales YoY Growth (2021-2032) & (k units) Figure 35. Global Endocrinology Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Endocrinology Drugs Market Share by Application 2025 VS 2032 Figure 37. North America Endocrinology Drugs Sales Market Share in Volume by Application in 2025 Figure 38. North America Endocrinology Drugs Sales Market Share in Value by Application in 2025 Figure 39. Europe Endocrinology Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Europe Endocrinology Drugs Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Endocrinology Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Endocrinology Drugs Sales Market Share in Value by Application in 2025 Figure 43. Latin America Endocrinology Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Endocrinology Drugs Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Endocrinology Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Endocrinology Drugs Sales Market Share in Value by Application in 2025 Figure 47. North America Endocrinology Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. North America Endocrinology Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Endocrinology Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Endocrinology Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Endocrinology Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Europe Endocrinology Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Endocrinology Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Endocrinology Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Endocrinology Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Asia-Pacific Endocrinology Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Endocrinology Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Endocrinology Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Endocrinology Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Latin America Endocrinology Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Endocrinology Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Endocrinology Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Endocrinology Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Middle East and Africa Endocrinology Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Endocrinology Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Endocrinology Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Endocrinology Drugs Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Endocrinology Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Diabetes Drugs
  • Human Growth Hormone Drugs
  • Thyroid Hormone Disorder Drugs
  • Testosterone Replacement Drugs
Applications
  • Ambulatory Care Centres
  • Commercial Laboratories
  • Hospitals
  • Other Setting
Companies covered
  • Sanofi
  • Novo Nordisk
  • Merck
  • Eli Lilly
  • AbbVie
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Endocrinology Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Endocrinology Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Endocrinology Drugs Market by Type
  6. 1.3.1 Diabetes Drugs
  7. 1.3.2 Human Growth Hormone Drugs
  8. 1.3.3 Thyroid Hormone Disorder Drugs
  9. 1.3.4 Testosterone Replacement Drugs
  10. 1.4 Global Endocrinology Drugs Market Size by Type
  11. 1.4.1 Global Endocrinology Drugs Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Endocrinology Drugs Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Endocrinology Drugs Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Endocrinology Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Endocrinology Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Endocrinology Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Endocrinology Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Endocrinology Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Endocrinology Drugs Industry Trends
  2. 2.2 Endocrinology Drugs Industry Drivers
  3. 2.3 Endocrinology Drugs Industry Opportunities and Challenges
  4. 2.4 Endocrinology Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Endocrinology Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Endocrinology Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Endocrinology Drugs Price (2021-2026)
  4. 3.4 Global Endocrinology Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Endocrinology Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Endocrinology Drugs Company, Product Type & Application
  7. 3.7 Global Endocrinology Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Endocrinology Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Endocrinology Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Endocrinology Drugs Tier 1, Tier 2, and Tier 3
4 Endocrinology Drugs Regional Status and Outlook
  1. 4.1 Global Endocrinology Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Endocrinology Drugs Historic Market Size by Region
  3. 4.2.1 Global Endocrinology Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Endocrinology Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Endocrinology Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Endocrinology Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Endocrinology Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Endocrinology Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Endocrinology Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Endocrinology Drugs by Application
  1. 5.1 Endocrinology Drugs Market by Application
  2. 5.1.1 Ambulatory Care Centres
  3. 5.1.2 Commercial Laboratories
  4. 5.1.3 Hospitals
  5. 5.1.4 Other Setting
  6. 5.2 Global Endocrinology Drugs Market Size by Application
  7. 5.2.1 Global Endocrinology Drugs Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Endocrinology Drugs Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Endocrinology Drugs Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Endocrinology Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Endocrinology Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Endocrinology Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Endocrinology Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Endocrinology Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Endocrinology Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Endocrinology Drugs Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Novo Nordisk
  8. 6.2.1 Novo Nordisk Company Information
  9. 6.2.2 Novo Nordisk Business Overview
  10. 6.2.3 Novo Nordisk Endocrinology Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novo Nordisk Endocrinology Drugs Product Portfolio
  12. 6.2.5 Novo Nordisk Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Endocrinology Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Endocrinology Drugs Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Eli Lilly
  20. 6.4.1 Eli Lilly Company Information
  21. 6.4.2 Eli Lilly Business Overview
  22. 6.4.3 Eli Lilly Endocrinology Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Eli Lilly Endocrinology Drugs Product Portfolio
  24. 6.4.5 Eli Lilly Recent Developments
  25. 6.5 AbbVie
  26. 6.5.1 AbbVie Company Information
  27. 6.5.2 AbbVie Business Overview
  28. 6.5.3 AbbVie Endocrinology Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 AbbVie Endocrinology Drugs Product Portfolio
  30. 6.5.5 AbbVie Recent Developments
  31. 6.6 AstraZeneca
  32. 6.6.1 AstraZeneca Company Information
  33. 6.6.2 AstraZeneca Business Overview
  34. 6.6.3 AstraZeneca Endocrinology Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 AstraZeneca Endocrinology Drugs Product Portfolio
  36. 6.6.5 AstraZeneca Recent Developments
7 North America by Country
  1. 7.1 North America Endocrinology Drugs Sales by Country
  2. 7.1.1 North America Endocrinology Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Endocrinology Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Endocrinology Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Endocrinology Drugs Market Size by Country
  6. 7.2.1 North America Endocrinology Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Endocrinology Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Endocrinology Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Endocrinology Drugs Sales by Country
  2. 8.1.1 Europe Endocrinology Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Endocrinology Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Endocrinology Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Endocrinology Drugs Market Size by Country
  6. 8.2.1 Europe Endocrinology Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Endocrinology Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Endocrinology Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Endocrinology Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Endocrinology Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Endocrinology Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Endocrinology Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Endocrinology Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Endocrinology Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Endocrinology Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Endocrinology Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Endocrinology Drugs Sales by Country
  2. 10.1.1 South America Endocrinology Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Endocrinology Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Endocrinology Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Endocrinology Drugs Market Size by Country
  6. 10.2.1 South America Endocrinology Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Endocrinology Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Endocrinology Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Endocrinology Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Endocrinology Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Endocrinology Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Endocrinology Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Endocrinology Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Endocrinology Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Endocrinology Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Endocrinology Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Endocrinology Drugs Value Chain Analysis
  2. 12.1.1 Endocrinology Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Endocrinology Drugs Production Mode & Process
  7. 12.2 Endocrinology Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Endocrinology Drugs Distributors
  10. 12.2.3 Endocrinology Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst